CHAMPIONS ONCOLOGY, INC.
www.discoverchampions.comAI Executive Summary
AI-powered analysis of 10-Q filing content
Champions Oncology has shifted from profitability to losses, reporting a $508k net loss for 9 months ended January 31, 2026 versus $6.5M profit in the prior year. Operating expenses increased 21.5% while revenue grew only 2.2%, indicating deteriorating operational efficiency and margin compression.
Red Flags Detected (5)
Net loss of $508k vs. $6.5M profit in prior year - 108% swing
Operating loss of $618k vs. $6.6M operating income - margin collapse
Cost of revenue increased 14.1% while revenue grew only 2.2%
2 more red flags detected
Key Takeaways
Revenue growth decelerated to only 2.2% vs. prior year
Gross margin compressed as cost of revenue outpaced sales growth
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.